Cargando…
SCFβ‐TrCP ubiquitinates CHK1 in an AMPK‐dependent manner in response to glucose deprivation
The ATR/CHK1 pathway is a key effector of cellular response to DNA damage and therefore is a critical regulator of genomic stability. While the ATR/CHK1 pathway is often inactivated by mutations, CHK1 itself is rarely mutated in human cancers. Thus, cellular levels of CHK1 likely play a key role in...
Autores principales: | Ma, Ying, Cui, Danrui, Xiong, Xiufang, Inuzuka, Hiroyuki, Wei, Wenyi, Sun, Yi, North, Brian J., Zhao, Yongchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360357/ https://www.ncbi.nlm.nih.gov/pubmed/30428154 http://dx.doi.org/10.1002/1878-0261.12403 |
Ejemplares similares
-
SCF(β-TrCP)-mediated degradation of TOP2β promotes cancer cell survival in response to chemotherapeutic drugs targeting topoisomerase II
por: Shu, Jianfeng, et al.
Publicado: (2020) -
SCF(β-TRCP) regulates osteoclastogenesis via promoting CYLD ubiquitination
por: Wu, Xiaomian, et al.
Publicado: (2014) -
Datasets from an interaction proteomics screen for substrates of the SCF(βTrCP) ubiquitin ligase
por: Magliozzi, Roberto, et al.
Publicado: (2015) -
The cross talk of two family members of β-TrCP in the regulation of cell autophagy and growth
por: Cui, Danrui, et al.
Publicado: (2019) -
SCF(β-TRCP) E3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradation
por: Ci, Yanpeng, et al.
Publicado: (2018)